Endocrinology of hirsutism

International Journal of Trichology

Volumn 2, Issue 1, 2010, Pages 30-35

  Kopera, Daisy ^a   Wehr, Elisabeth ^b   Obermayer Pietsch, Barbara ^b  

^a Universitatsklinik fur Dermatologie und Venerologie   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Endocrinology; hirsutism; medical treatment; polycystic ovary syndrome

Indexed keywords

EID: 84863839849     PISSN: 09747753     EISSN: 09749241     Source Type: Journal    
DOI: 10.4103/0974-7753.66910     Document Type: Review

References (16)

1. Dunaif A. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis. Endocr Rev 1997;18:774-800.
2. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: Hormonal and metabolic profile. J Clin Endocrinol Metab 1999;84:4006-11.
3. Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434-8.
4. Heutling D, Schulz H, Randeva H, Dodt C, Lehnert H. Polycystic ovary syndrome: Prototype of a cardio-metabolic syndrome. Internist (Berl) 2007;48:144-53.
5. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;352:1223-36.
6. Rotterdam ESHRE/ASRM-Sponsored consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-7.
7. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: The complete task force report. Fertil Steril 2009;91:456-88.
8. Li X, Lin J F. Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome. Zhonghua Yi Xue Za Zhi 2005;85:3266-71.
9. Robinson S, Rodin DA, Deacon A, Wheeler MJ, Clayton RN. Which hormone tests for the diagnosis of polycystic ovary syndrome? Br J Obstet Gynaecol 1992;99:232-8.
10. Escobar-Morreale HF, Luque-Ramirez M, San Millan JL. The moleculargenetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev 2005;26:251-82.
11. Recabarren SE, Smith R, Rios R, Maliqueo M, Echiburú B, Codner E, et al. Metabolic profile in sons of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2008;93:1820-6.
12. Lowenstein EJ. Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome. Dermatol Ther 2006;19:210-23.
13. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: Implications, etiology, and management. Am J Obstet Gynecol 1981;140:815-30.
14. Glueck CJ, Wang P, Fontaine RN, Sieve-Smith L, Tracy T, Moore SK. Plasminogen activator inhibitor activity: An independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome. Metabolism 1999;48:1589-95.
15. Pasquali R, Gambineri A. Insulin-sensitizing agents in polycystic ovary syndrome. Eur J Endocrinol 2006;154:763-75.
16. Classen M, Diehl V, Kochsiek K. Innere Medizin. Urban and Fischer Verlag München, Jena 2004.